Murdin A D, Wimmer E
Department of Microbiology, State University of New York, Stony Brook 11794-8621.
J Virol. 1989 Dec;63(12):5251-7. doi: 10.1128/JVI.63.12.5251-5257.1989.
There are three serotypes of poliovirus, poliovirus type 1 (PV-1), PV-2, and PV-3. These viruses each display four distinct neutralization antigenic sites, designated N-AgI, N-AgII, N-AgIIIA, and N-AgIIIB. It has been demonstrated previously that part of N-AgI can be replaced with heterogeneous amino acid sequences, resulting in hybrid viruses expressing heterogeneous antigenic determinants. To study whether hybrid viruses could be constructed by modifying another antigenic site, a part of N-AgII (amino acids 158 to 173 of VP2) of PV-1(Mahoney) was replaced with the equivalent sequence from PV-2(Lansing). The resulting hybrid was viable and expressed both PV-1 and PV-2 antigenic determinants. When inoculated into rabbits, the hybrid induced neutralizing antibodies against both PV-1 and PV-2, showing that amino acids 158 to 173 of VP2 are able to function as an antigenic site independent of the rest of N-AgII. Manipulation of N-AgII represents a useful alternative method for the production of hybrid polioviruses.
脊髓灰质炎病毒有三种血清型,即脊髓灰质炎病毒1型(PV-1)、PV-2和PV-3。这些病毒各自呈现出四个不同的中和抗原位点,分别命名为N-AgI、N-AgII、N-AgIIIA和N-AgIIIB。先前已经证明,N-AgI的一部分可以被异源氨基酸序列取代,从而产生表达异源抗原决定簇的杂交病毒。为了研究是否可以通过修饰另一个抗原位点来构建杂交病毒,将PV-1(Mahoney)的N-AgII的一部分(VP2的第158至173位氨基酸)替换为PV-2(Lansing)的相应序列。产生的杂交病毒是有活力的,并且表达了PV-1和PV-2的抗原决定簇。当接种到兔子体内时,该杂交病毒诱导产生了针对PV-1和PV-2的中和抗体,表明VP2的第158至173位氨基酸能够作为一个独立于N-AgII其余部分的抗原位点发挥作用。对N-AgII的操作是生产杂交脊髓灰质炎病毒的一种有用的替代方法。